Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1996-2-26
|
pubmed:abstractText |
Chronic lymphocytic leukemia (CLL), a proliferative disease of mature looking B lymphocytes, is the commonest leukemia in western countries. It remains incurable by available treatment modalities. We report on the establishment of a permanent, EBV-negative, B-CLL line (WSU-CLL) from the peripheral blood of a patient with CLL. The cells grow as suspension in liquid culture, express IgG lambda and other B cell markers and show lg heavy and light gene rearrangements. Karyotypic analysis shows 45,X,del(3)(p14;p24),t(4;12;12) (q31;q22;p13), t(5;12) (q31;p13), add(16)(q24)X2, t(18;21) (q12;p12). WSU-CLL forms colonies when grown on soft agar. A xenograft model was established by injecting the WSU-CLL cells subcutaneously (s.c.) in severe combined immune deficient (SCID) mice. When the s.c. tumor was transplanted in vivo to other SCID mice, the success rate was 100% with a doubling time of 7.3 days. The CLL-SCID xenograft model was used to test the efficacy of selected standard chemotherapy drugs and new therapeutic agents against WSU-CLL. The cell line and the xenograft described can be used as a model to facilitate the development of new therapeutic agents against CLL in man.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
130-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8558918-Aged,
pubmed-meshheading:8558918-Animals,
pubmed-meshheading:8558918-Antineoplastic Agents,
pubmed-meshheading:8558918-Chromosome Aberrations,
pubmed-meshheading:8558918-Disease Models, Animal,
pubmed-meshheading:8558918-Drug Screening Assays, Antitumor,
pubmed-meshheading:8558918-Humans,
pubmed-meshheading:8558918-Immunophenotyping,
pubmed-meshheading:8558918-Karyotyping,
pubmed-meshheading:8558918-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:8558918-Male,
pubmed-meshheading:8558918-Mice,
pubmed-meshheading:8558918-Mice, SCID,
pubmed-meshheading:8558918-Neoplasm Transplantation,
pubmed-meshheading:8558918-Transplantation, Heterologous,
pubmed-meshheading:8558918-Tumor Cells, Cultured
|
pubmed:year |
1996
|
pubmed:articleTitle |
Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
|
pubmed:affiliation |
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|